CECILIA HALL: Open Payments
NPI 1568224756 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $233 |
| Novo Nordisk Inc | 6 | $180 |
| ABBVIE INC. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Organon LLC | 1 | $20 |
| Amgen Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: AIRSUPRA, Ozempic, QULIPTA, Veozah, PAXLOVID, Wegovy, NEXPLANON, Rybelsus.
Industry payments across FL — which companies pay providers there.
